Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardioprotection Through Mitochondrial Modulation: A Systematic Review of Pharmacological Interventions in Animal Models of I/R Injury.

Cardiovascular drugs and therapy·2026
Same author

A systematic review of transgender male rodent model methodology.

Animal models and experimental medicine·2025
Same author

Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study.

Diagnostics (Basel, Switzerland)·2025
Same author

An investigation into the sex dependence of post-reperfusion cardiac mitochondrial function and redox balance in chronically stressed rats.

Physiological reports·2025
Same author

The Role of Chronic Stress in the Pathogenesis of Ischemic Heart Disease in Women.

Comprehensive Physiology·2025
Same author

Effects of chronic stress on rat heart function following regional ischemia: a sex-dependent investigation.

American journal of physiology. Heart and circulatory physiology·2024

Related Experiment Video

Updated: Jun 16, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Nitric oxide triggers classic ischemic preconditioning.

Amanda Lochner1, Erna Marais, Eugene Du Toit

  • 1Diabetes Research Group, MRC of South Africa, Republic of South Africa. alo@gerga.sun.ac.za

Annals of the New York Academy of Sciences
|June 22, 2002
PubMed
Summary

Nitric oxide (NO) triggers myocardial preconditioning, offering protection against ischemia. This protection involves cGMP and reduced p38 MAPK activity, suggesting NO preconditioning may be superior to ischemic preconditioning.

More Related Videos

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Related Experiment Videos

Last Updated: Jun 16, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology

Background:

  • The precise role of nitric oxide (NO) in myocardial ischemic preconditioning remains unclear.
  • Investigating NO's involvement is crucial for understanding cardiac protection mechanisms.

Purpose of the Study:

  • To elucidate the role of NO in the classic ischemic preconditioning of the myocardium.
  • To compare the protective effects of NO-donor preconditioning versus traditional ischemic preconditioning.

Main Methods:

  • Utilized an isolated perfused rat heart model.
  • Administered nitric oxide synthase (NOS) inhibitors (L-NAME, L-NNA) and guanylyl cyclase inhibitor (ODQ) during ischemic preconditioning.
  • Applied NO donors (SNAP, SNP) for preconditioning and assessed functional recovery and p38 MAPK activation.

Main Results:

  • NOS and guanylyl cyclase inhibition significantly reduced the protective effects of ischemic preconditioning.
  • NO donors (SNAP, SNP) provided protection against both global and low-flow ischemia.
  • NO-donor preconditioning resulted in superior functional reserve compared to ischemic preconditioning.
  • Both NO donors and ischemic preconditioning decreased p38 MAPK activity during sustained ischemia.

Conclusions:

  • Nitric oxide (NO) acts as a trigger for classic myocardial preconditioning.
  • Cyclic guanosine monophosphate (cGMP) generation is vital for NO-mediated cardioprotection.
  • Reduced p38 MAPK activity during sustained ischemia may mediate NO-induced cardiac protection.
  • Preconditioning with NO may offer greater advantages than ischemic preconditioning.